The Impact of Chronic Metabolic Disorders on Cognitive Decline and Dementia Progression

Abstract

Background: Chronic metabolic disorders, including Type 2 Diabetes Mellitus (T2DM), systemic hypertension, and dyslipidemia, are increasingly recognized as potent independent risk factors for cognitive impairment. As the global prevalence of metabolic syndrome rises, understanding its role in the pathophysiology of the aging brain becomes a critical public health priority.

Objective: This chapter examines the multi-faceted mechanisms by which metabolic dysfunction accelerates neurodegeneration and contributes to the progression of various forms of dementia, particularly Alzheimer’s Disease and Vascular Dementia.

Discussion: The research highlights the "metabolic-cognitive axis," focusing on three primary pathways: chronic neuroinflammation, oxidative stress, and cerebrovascular compromise. We explore how insulin resistance in the brain—often termed "Type 3 Diabetes"—impairs neuronal glucose metabolism and triggers the accumulation of amyloid-beta plaques and tau tangles. Additionally, the chapter discusses how persistent hypertension leads to microvascular damage, resulting in white matter hyperintensities and reduced cerebral blood flow.

Significance: Evidence suggests that metabolic disorders do not just coexist with cognitive decline but actively drive its severity. By identifying metabolic markers as early predictors of neurodegeneration, this study advocates for an integrated "Whole-Patient" approach. Managing glycemic control and vascular health is presented not only as a treatment for metabolic disease but as a primary preventative strategy for preserving cognitive integrity in aging populations.